Ni Jiang

Chongqing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Corrigendum to "Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2" [Heliyon Volume 10 Issue 12 June 2024 Article e32025].

Corrigendum to "Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2" [Heliyon Volume 10 Issue 12 June 2024 Article e32025].

Journal: Heliyon
Published: November 11, 2025

Decreased IL20RA expression serves as a predictor of unfavorable prognosis in endometrial cancer.

Decreased IL20RA expression serves as a predictor of unfavorable prognosis in endometrial cancer.

Journal: Discover oncology
Published: May 21, 2025

Roles, mechanisms, and clinical implications of circHIPK3 in female malignancy: a comprehensive review.

Roles, mechanisms, and clinical implications of circHIPK3 in female malignancy: a comprehensive review.

Journal: Discover oncology
Published: May 03, 2025

Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma.

Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma.

Journal: Aging
Published: October 16, 2023

Inhibition of UFM1 expression suppresses cancer progression and is linked to the dismal prognosis and immune infiltration in oral squamous cell carcinoma.

Inhibition of UFM1 expression suppresses cancer progression and is linked to the dismal prognosis and immune infiltration in oral squamous cell carcinoma.

Journal: Aging
Published: June 06, 2023

A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients.

A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients.

Journal: Aging
Published: May 24, 2023

Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2.

Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2.

Journal: Heliyon
Published: May 04, 2023

TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.

TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.

Journal: PloS one
Published: March 22, 2023

A new prognostic model for RHOV, ABCC2, and CYP4B1 to predict the prognosis and association with immune infiltration of lung adenocarcinoma.

A new prognostic model for RHOV, ABCC2, and CYP4B1 to predict the prognosis and association with immune infiltration of lung adenocarcinoma.

Journal: Journal of thoracic disease
Published: February 07, 2023

Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway.

Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway.

Journal: Journal of thoracic disease
Published: January 31, 2023

The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma.

The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma.

Journal: BMC cancer
Published: December 14, 2022

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer.

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer.

Journal: Mediators of inflammation
Published: December 10, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026